Welcome to Pharmacovigilance 2.0

VigiBase global adverse event data, integrated in Evidex alongside proprietary clinical trials safety outcomes data, optimized post-approval spontaneous reporting data from the FDA Adverse Event Reporting System (FAERS), and other real-world data sources provides pharmacovigilance professionals with the software, data, and anlaytics to track emerging safety issues through multiple data sets, validate signals seen in other reporting, and engage across these various data sets in a dynamic and proactive manner. 

About Evidex®

Advera Health’s Evidex® is a drug safety data aggregation platform that makes disparate drug safety data actionable though a simple to use yet powerful web-based application, empowering use at all organizational levels. Evidex is the gold standard resource for drug safety knowledge and insight, generated through proprietary curated data and analytics and powerful data integrations, enabling previously unavailable in-depth, rigorous adverse event analysis.


110 Countries 15M Cases

Developed and maintained by the Uppsala Monitoring Centre in partnership with the WHO, VigiBase is the only consolidated resource of global adverse event data.


Fully Integrated with Evidex

Native integration between VigiBase and Evidex allows for standardized views, but with the flexibility for deeper customization


Powerful Signal Management

Evidex + VigiBase = a clear view into the same data required to meet EMA GVP Module IX requirements. Read more on signal management in Pharmacovigilance Signal Detection: The Complete Guide.

New Call-to-action